211 related articles for article (PubMed ID: 34975523)
21. Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis.
Zoja C; Benigni A; Camozzi D; Corna D; Longaretti L; Todeschini M; Remuzzi G
Kidney Int; 2003 Sep; 64(3):857-63. PubMed ID: 12911535
[TBL] [Abstract][Full Text] [Related]
22. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
[TBL] [Abstract][Full Text] [Related]
23. Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies.
Cinotti GA; Zucchelli PC;
Nephrol Dial Transplant; 2001 May; 16(5):961-6. PubMed ID: 11328901
[TBL] [Abstract][Full Text] [Related]
24. Loss of
Johnson AC; Wu W; Attipoe EM; Sasser JM; Taylor EB; Showmaker KC; Kyle PB; Lindsey ML; Garrett MR
Hypertension; 2020 Apr; 75(4):1012-1024. PubMed ID: 32148127
[No Abstract] [Full Text] [Related]
25. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
Zoja C; Donadelli R; Corna D; Testa D; Facchinetti D; Maffi R; Luzzana E; Colosio V; Bertani T; Remuzzi G
Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
[TBL] [Abstract][Full Text] [Related]
26. The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat.
Habibi J; Aroor AR; Das NA; Manrique-Acevedo CM; Johnson MS; Hayden MR; Nistala R; Wiedmeyer C; Chandrasekar B; DeMarco VG
Cardiovasc Diabetol; 2019 Mar; 18(1):40. PubMed ID: 30909895
[TBL] [Abstract][Full Text] [Related]
27. Role of 20-HETE in the antihypertensive effect of transfer of chromosome 5 from Brown Norway to Dahl salt-sensitive rats.
Williams JM; Fan F; Murphy S; Schreck C; Lazar J; Jacob HJ; Roman RJ
Am J Physiol Regul Integr Comp Physiol; 2012 May; 302(10):R1209-18. PubMed ID: 22442195
[TBL] [Abstract][Full Text] [Related]
28. Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: a prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency.
Mitchell HC; Smith RD; Cutler RE; Sica D; Videen J; Thompsen-Bell S; Jones K; Bradley-Guidry C; Toto RD
Am J Kidney Dis; 1997 Jun; 29(6):897-906. PubMed ID: 9186076
[TBL] [Abstract][Full Text] [Related]
29. Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition.
Macconi D; Sangalli F; Bonomelli M; Conti S; Condorelli L; Gagliardini E; Remuzzi G; Remuzzi A
Am J Pathol; 2009 Mar; 174(3):797-807. PubMed ID: 19164508
[TBL] [Abstract][Full Text] [Related]
30. Renal protective effect of N-acetyl-seryl-aspartyl-lysyl-proline in dahl salt-sensitive rats.
Worou ME; Liao TD; D'Ambrosio M; Nakagawa P; Janic B; Peterson EL; Rhaleb NE; Carretero OA
Hypertension; 2015 Oct; 66(4):816-22. PubMed ID: 26324505
[TBL] [Abstract][Full Text] [Related]
31. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy.
Remuzzi A; Fassi A; Bertani T; Perico N; Remuzzi G
Am J Kidney Dis; 1999 Oct; 34(4):626-32. PubMed ID: 10516341
[TBL] [Abstract][Full Text] [Related]
32. Effects of lipid-lowering agents in the Dahl salt-sensitive rat.
Wilson TW; Alonso-Galicia M; Roman RJ
Hypertension; 1998 Jan; 31(1 Pt 2):225-31. PubMed ID: 9453307
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.
Williams JM; Zhang J; North P; Lacy S; Yakes M; Dahly-Vernon A; Roman RJ
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F983-98. PubMed ID: 21228113
[TBL] [Abstract][Full Text] [Related]
34. Lisinopril Mitigates Radiation-Induced Mitochondrial Defects in Rat Heart and Blood Cells.
Ortiz de Choudens S; Sparapani R; Narayanan J; Lohr N; Gao F; Fish BL; Zielonka M; Gasperetti T; Veley D; Beyer A; Olson J; Jacobs ER; Medhora M
Front Oncol; 2022; 12():828177. PubMed ID: 35311118
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
Remuzzi A; Malanchini B; Battaglia C; Bertani T; Remuzzi G
Exp Nephrol; 1996; 4(1):19-25. PubMed ID: 8788596
[TBL] [Abstract][Full Text] [Related]
36. Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension.
Tian N; Gu JW; Jordan S; Rose RA; Hughson MD; Manning RD
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1018-25. PubMed ID: 17040973
[TBL] [Abstract][Full Text] [Related]
37. Null mutation of the nicotinamide adenine dinucleotide phosphate-oxidase subunit p67phox protects the Dahl-S rat from salt-induced reductions in medullary blood flow and glomerular filtration rate.
Evans LC; Ryan RP; Broadway E; Skelton MM; Kurth T; Cowley AW
Hypertension; 2015 Mar; 65(3):561-8. PubMed ID: 25489057
[TBL] [Abstract][Full Text] [Related]
38. Progression of renal failure with anaemia and multiple effects of angiotensin-converting enzyme inhibitor in rats with renal mass reduction.
Yatsu T; Sanagi M; Fujimori A; Tomura Y; Hayashi K; Tanahashi M; Inagaki O
Pharmacol Res; 2003 Mar; 47(3):243-52. PubMed ID: 12591020
[TBL] [Abstract][Full Text] [Related]
39. Brown Norway chromosome 13 confers protection from high salt to consomic Dahl S rat.
Cowley AW; Roman RJ; Kaldunski ML; Dumas P; Dickhout JG; Greene AS; Jacob HJ
Hypertension; 2001 Feb; 37(2 Pt 2):456-61. PubMed ID: 11230318
[TBL] [Abstract][Full Text] [Related]
40. Selective loss of podoplanin protein expression accompanies proteinuria and precedes alterations in podocyte morphology in a spontaneous proteinuric rat model.
Koop K; Eikmans M; Wehland M; Baelde H; Ijpelaar D; Kreutz R; Kawachi H; Kerjaschki D; de Heer E; Bruijn JA
Am J Pathol; 2008 Aug; 173(2):315-26. PubMed ID: 18599604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
